Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2005 Feb;60(2):124–129. doi: 10.1136/thx.2003.017970

Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong

C Leung 1, W Yew 1, C Tam 1, C Chan 1, K Chang 1, W Law 1, S Lee 1, M Wong 1, K Au 1
PMCID: PMC1747293  PMID: 15681500

Abstract

Background: In Hong Kong there has been nearly universal neonatal BCG vaccination coverage since 1980.

Method: 21 113 schoolchildren aged 6–9 years were skin tested with one unit of tuberculin (PPD RT-23) using the intradermal technique during a routine BCG revaccination programme. Information on sex, date of birth, date of tuberculin testing, and tuberculin reaction size at 72 hours was retrieved. The annual risk of tuberculous infection (ARTI) was estimated by three different approaches.

Results: Significantly higher tuberculin positive rates were found in girls and with increasing age at all commonly used cut-off points (5, 10, and 15 mm). Using a cut-off point of ⩾10 mm and the formula 1– (1 – tuberculin positive rate)1/age, the ARTI was estimated to be 1.93% (95% CI 1.84 to 2.03) for girls and 1.41% (95% CI 1.33 to 1.50) for boys. Using the differences in the tuberculin positive rate between the 6–7 year and 8–9 year age groups, the ARTI became 1.90% (95% CI 1.09 to 2.70) and 1.84% (95% CI 1.15 to 2.54) for girls and boys, respectively. When the prevalence of infection was estimated by locating a secondary peak of the tuberculin reaction distribution curve at 15 mm and assuming a symmetrical distribution of reaction sizes among those infected around this peak, the corresponding ARTI was much lower at 0.52% (95% CI 0.46 to 0.59) and 0.43% (95% CI 0.37 to 0.49) for girls and boys, similar to that estimated indirectly from the prevalence of disease.

Conclusion: The ARTI as estimated by conventional methods was unexpectedly high among BCG vaccinated children and did not agree with that anticipated from the annual incidence of active disease. Further studies are needed to address the discrepancies, including the possible interaction between BCG and other environmental stimuli.

Full Text

The Full Text of this article is available as a PDF (110.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al Jarad N., Empey D. W., Duckworth G. Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method. Thorax. 1999 Sep;54(9):762–764. doi: 10.1136/thx.54.9.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnadottir T., Rieder H. L., Trébucq A., Waaler H. T. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis. 1996 Jun;77 (Suppl 1):1–19. doi: 10.1016/s0962-8479(96)90127-6. [DOI] [PubMed] [Google Scholar]
  3. Bozaykut A., Ipek I. Ozahi, Ozkars M. Y., Seren L. Pulat, Atay E., Atay Z. Effect of BCG vaccine on tuberculin skin tests in 1-6-year-old children. Acta Paediatr. 2002;91(2):235–238. doi: 10.1080/080352502317285270. [DOI] [PubMed] [Google Scholar]
  4. Bull H., Choy M., Manyonda I., Brown C. A., Waldron E. E., Holmes S. D., Booth J. C., Nelson P. N. Reactivity and assay restriction profiles of monoclonal and polyclonal antibodies to acid phosphatases: a preliminary study. Immunol Lett. 1999 Dec 1;70(3):143–149. doi: 10.1016/s0165-2478(99)00154-6. [DOI] [PubMed] [Google Scholar]
  5. Chee C. B., Soh C. H., Boudville I. C., Chor S. S., Wang Y. T. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med. 2001 Sep 15;164(6):958–961. doi: 10.1164/ajrccm.164.6.2101093. [DOI] [PubMed] [Google Scholar]
  6. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M. C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999 Aug 18;282(7):677–686. doi: 10.1001/jama.282.7.677. [DOI] [PubMed] [Google Scholar]
  7. Ewer Katie, Deeks Jonathan, Alvarez Lydia, Bryant Gerry, Waller Sue, Andersen Peter, Monk Philip, Lalvani Ajit. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003 Apr 5;361(9364):1168–1173. doi: 10.1016/S0140-6736(03)12950-9. [DOI] [PubMed] [Google Scholar]
  8. Ferebee S. H. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28–106. [PubMed] [Google Scholar]
  9. Fine P. E., Ponnighaus J. M., Maine N. The distribution and implications of BCG scars in northern Malawi. Bull World Health Organ. 1989;67(1):35–42. [PMC free article] [PubMed] [Google Scholar]
  10. Fine P. E., Sterne J. A., Pönnighaus J. M., Rees R. J. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet. 1994 Nov 5;344(8932):1245–1249. doi: 10.1016/s0140-6736(94)90748-x. [DOI] [PubMed] [Google Scholar]
  11. Floyd S., Ponnighaus J. M., Bliss L., Warndorff D. K., Kasunga A., Mogha P., Fine P. E. BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size. Int J Tuberc Lung Dis. 2000 Dec;4(12):1133–1142. [PubMed] [Google Scholar]
  12. Jentoft H. F., Omenaas E., Eide G. E., Gulsvik A. Tuberculin reactivity: prevalence and predictors in BCG-vaccinated young Norwegian adults. Respir Med. 2002 Dec;96(12):1033–1039. doi: 10.1053/rmed.2002.1386. [DOI] [PubMed] [Google Scholar]
  13. Karalliedde S., Katugaha L. P., Uragoda C. G. Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle. 1987 Mar;68(1):33–38. doi: 10.1016/0041-3879(87)90005-5. [DOI] [PubMed] [Google Scholar]
  14. Leung C. C., Tam C. M., Chan S. L., Chan-Yeung M., Chan C. K., Chang K. C. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis. 2001 Aug;5(8):717–723. [PubMed] [Google Scholar]
  15. Menzies R., Vissandjee B. Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992 Mar;145(3):621–625. doi: 10.1164/ajrccm/145.3.621. [DOI] [PubMed] [Google Scholar]
  16. Ramakrishnan R., Rao T. V., Sundaramoorthy L., Joshua V. Magnitude of recall bias in the estimation of immunization coverage and its determinants. Indian Pediatr. 1999 Sep;36(9):881–885. [PubMed] [Google Scholar]
  17. Rani S. H., Vijayalakshmi V., Sunil K., Lakshmi K. A., Suman L. G., Murthy K. J. Cell mediated immunity in children with scar-failure following BCG vaccination. Indian Pediatr. 1998 Feb;35(2):123–127. [PubMed] [Google Scholar]
  18. Sepulveda R. L., Burr C., Ferrer X., Sorensen R. U. Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Guérin at birth in Santiago, Chile. Pediatr Infect Dis J. 1988 Aug;7(8):578–581. [PubMed] [Google Scholar]
  19. Sepulveda R. L., Ferrer X., Latrach C., Sorensen R. U. The influence of Calmette-Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis. 1990 Jul;142(1):24–28. doi: 10.1164/ajrccm/142.1.24. [DOI] [PubMed] [Google Scholar]
  20. Smeja C., Brassard P. Tuberculosis infection in an Aboriginal (First Nations) population of Canada. Int J Tuberc Lung Dis. 2000 Oct;4(10):925–930. [PubMed] [Google Scholar]
  21. Sudre P., ten Dam G., Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ. 1992;70(2):149–159. [PMC free article] [PubMed] [Google Scholar]
  22. Tala-Heikkilä M., Nurmela T., Misljenovic O., Bleiker M. A., Tala E. Sensitivity to PPD tuberculin and M. scrofulaceum sensitin in schoolchildren BCG vaccinated at birth. Tuber Lung Dis. 1992 Apr;73(2):87–93. doi: 10.1016/0962-8479(92)90061-N. [DOI] [PubMed] [Google Scholar]
  23. Thompson N. J., Glassroth J. L., Snider D. E., Jr, Farer L. S. The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis. 1979 Apr;119(4):587–597. doi: 10.1164/arrd.1979.119.4.587. [DOI] [PubMed] [Google Scholar]
  24. Tupasi T. E., Radhakrishna S., Pascual M. L., Quelapio M. I., Villa M. L., Co V. M., Sarol J., Mangubat N., Reyes A. C., Sarmiento A. BCG coverage and the annual risk of tuberculosis infection over a 14-year period in the Philippines assessed from the Nationwide Prevalence Surveys. Int J Tuberc Lung Dis. 2000 Mar;4(3):216–222. [PubMed] [Google Scholar]
  25. Wang L., Turner M. O., Elwood R. K., Schulzer M., FitzGerald J. M. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax. 2002 Sep;57(9):804–809. doi: 10.1136/thorax.57.9.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yorulmaz F., Cağlar T., Erel C., Ozaydin M. Prevalence and annual risk of tuberculosis infection in Edirne, Turkey. Scand J Infect Dis. 2002;34(9):654–656. doi: 10.1080/00365540210147750. [DOI] [PubMed] [Google Scholar]
  27. al-Kassimi F. A., Abdullah A. K., al-Orainey I. O., Benar A. B., al-Hajjaj M. S., al-Majed S., al-Wazzan A. The significance of positive Mantoux reactions in BCG-vaccinated children. Tubercle. 1991 Jun;72(2):101–104. doi: 10.1016/0041-3879(91)90035-q. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES